HIGHLIGHTS
- who: Mater H. Mahnashi and colleagues from the Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia have published the research work: Exploration of Succinimide Derivative as a Multi-Target, Anti-Diabetic Agent: In Vitro and In Vivo Approaches, in the Journal: Molecules 2023, 1589 of /2023/
- what: The aim of this research is to exhibit the developed compound 3`s ability to concurrently inhibit many targets that are responsible for hyperglycemia. The aim of this research is to studies so much attractive thatCompound it is why 3 the authors theinhibit current . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.